You have 9 free searches left this month | for more free features.

stem cell transplantation

Showing 9926 - 9950 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))

Not yet recruiting
  • Lymphoma Leukemia
  • allogeneic CAR19 regulatory T cells (CAR19-tTreg)
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Dec 6, 2022

Type 1 Diabetes Trial in Kuwait City (drug, other, procedure)

Not yet recruiting
  • Type 1 Diabetes
  • Liraglutide / Semaglutide
  • +4 more
  • Kuwait City, Al Asimah, Kuwait
    Dasman Diabetes Institute
Jan 8, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Spinal Canal Stenosis, Spondylolisthesis, Osteophyte Trial in Columbus (Medtronic Adaptix™ titanium implants, Medtronic

Recruiting
  • Spinal Canal Stenosis
  • +4 more
  • Medtronic Adaptix™ titanium implants
  • Medtronic CAPSTONE® PEEK cage
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center Neurological Sur
Jan 6, 2022

Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

Completed
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Truro, Cornwall, United Kingdom
  • +35 more
May 18, 2022

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • CTLA4 Haploinsufficency
  • Chronic Cytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Coronavirus Infection Trial in Liège (Mesenchymal stromal cells)

Recruiting
  • Coronavirus Infection
  • Mesenchymal stromal cells
  • Liège, Belgium
    CHU de Liège
Sep 19, 2022

Hybrid Closed-Loop Insulin Delivery System in Type 1 Diabetes

Withdrawn
  • Diabetes, Type 1
  • Observation
  • New Haven, Connecticut
    Yale-New Haven Organ Transplant Center
Mar 4, 2021

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Extra-Pulmonary Small Cell Carcinomas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    NSCLC Trial (herombopag olamine tablets)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • herombopag olamine tablets
    • (no location specified)
    Feb 14, 2022

    Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

    Completed
    • Prostate Cancer Metastatic
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 6, 2022

    Esophageal Squamous Cell Carcinoma, Stage III Trial in Tianjin (Pembrolizumab Injection [Keytruda])

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Stage III
    • Pembrolizumab Injection [Keytruda]
    • Tianjin, Tianjin, China
      Department of minimally invasive esophageal surgery, Tianjin Med
    Mar 9, 2022

    Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

    Recruiting
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Metastatic Malignant Neoplasm in the Spine
    • Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 13, 2022

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023

      NSCLC Trial in Lexington (Molecular tumor board assisted care)

      Recruiting
      • Non-Small Cell Lung Cancer
      • Molecular tumor board assisted care
      • Lexington, Kentucky
        University of Kentucky
      Apr 13, 2022

      Covid19 Trial in United States (COVI-MSC, Placebo)

      Recruiting
      • Covid19
      • COVI-MSC
      • Placebo
      • Brandon, Florida
      • +5 more
      Apr 7, 2022

      CD160 Expression in Corneal Vessels

      Not yet recruiting
      • Corneal Graft Rejection
      • +3 more
      • Immunohistochemistry and clinical analyses on patients and corneas
      • Reims, France
        Damien JOLLY
      Aug 11, 2021

      Organ Transplant Failure or Rejection, Brain Death, Ischemic Reperfusion Injury Trial in Canada (Tacrolimus, Placebo)

      Not yet recruiting
      • Organ Transplant Failure or Rejection
      • +2 more
      • Hamilton, Ontario, Canada
      • +13 more
      Dec 7, 2021

      Non-Squamous NSCLC Trial in Guangzhou (AK112 Injection, Placebo Injection)

      Recruiting
      • Non-Squamous Non-small Cell Lung Cancer
      • AK112 Injection
      • Placebo Injection
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 23, 2022

      Bone Nonunion Trial in Jinan (Umbilical cord blood mononuclear cells, Staphylococcal Enterotoxin C)

      Recruiting
      • Bone Nonunion
      • Umbilical cord blood mononuclear cells
      • Staphylococcal Enterotoxin C
      • Jinan, Shandong, China
        China, Shandong Qianfoshan Hospital
      Aug 2, 2021

      Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

      Recruiting
      • Plasma Cell Myeloma
      • +2 more
      • Belantamab Mafodotin
      • +4 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jun 10, 2022

      Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,

      Not yet recruiting
      • Locally Advanced Lung Non-Small Cell Carcinoma
      • +2 more
      • (no location specified)
      Nov 14, 2022